Saleh, Tareq

Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy.

Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A. (2019) · Cancer Research

Telomeres, Telomerase, and SenescenceCancer Cells and Metastasis

Cited by 259

Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction

Saleh, T., Carpenter, V. J., Tyutyunyk‐Massey, L., Murray, G., Leverson, J. D., Souers, A. J., Alotaibi, M. R., Faber, A. C., Reed, J., Harada, H., et al. (2020) · Molecular Oncology

Telomeres, Telomerase, and SenescenceCell death mechanisms and regulation

Cited by 190

Tumor cell escape from therapy-induced senescence

Saleh, T., Tyutyunyk-Massey, L., Murray, G. F., Alotaibi, M. R., Kawale, A. S., Elsayed, Z., Henderson, S. C., Yakovlev, V., Elmore, L. W., Toor, A., et al. (2019) · Biochemical Pharmacology

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 182

Senolytics for Cancer Therapy: Is All that Glitters Really Gold?

Carpenter, V. J., Saleh, T., & Gewirtz, D. A. (2021) · Cancers

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 124

Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.

Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 85